Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Type 2 MI and Myocardial Injury in the Era of High-sensitivity Troponin
Author(s): Rifly Rafiudeen , Peter Barlis , Harvey D White , et al Added: 2 years ago

Vascular Disease and Surgery
Author(s): Roland Klingenberg , Christian M Matter , Christophe Wyss , et al Added: 3 years ago
Abstract The introduction of novel high-sensitivity cardiac troponin (hs-cTn) assays has made it possible to measure cardiac troponin levels that are up to 10-fold lower than those detectable by conventional cardiac troponin (cTn) assays. With such novel assays, an elevated risk of major adverse cardiovascular events was noted across the continuum of cTn levels, with an incremental risk of… View more

MI/ACS
AHA 23: 3 Trials That Will Change My Practice
Author(s): Purvi Parwani Added: 5 months ago
AHA 23 — Dr Purvi Parwani, cardiologist and multimodality imager, and director of the Women's Heart Clinic at Loma Linda University Health in the US, spotlights three game-changing late-breaking science trials from the AHA Scientific Sessions. Discover the trials anticipated to reshape clinical practices as Dr Parwani shares her insights.Trials discussed in detail include:POP-HT: Cardiac… View more

Standards & Guidelines

Prevention & Chronic Conditions
Troponin in Non-ischaemic Dilated Cardiomyopathy
Author(s): Andrea Barison , Luigi Emilio Pastormerlo , Alberto Giannoni Added: 3 years ago
Among the various cardiovascular diseases, non-ischaemic dilated cardiomyopathy (DCM) represents a major cause of morbidity and mortality.1 DCM is characterised by the presence of left ventricular dilatation and systolic dysfunction in the absence of coronary artery disease or abnormal loading conditions (hypertension, valvular disease).2 It originates from several aetiologies and includes… View more

Heart Failure
Author(s): Christian Mueller , Evangelos Giannitsis , James L Januzzi Added: 3 years ago
Improvements in the Early Diagnosis of Acute Myocardial Infarction using a Cardiac Troponin T-high Sensitive Assay In the first talk, Christian Mueller, a Professor at the University Hospital in Basel, discussed the unmet needs of current troponin assays and the improvements made in the early diagnosis of acute myocardial infarction (AMI) using the latest cardiac troponin T-high sensitive (cTnT… View more

MI/ACS
CV Risk Biomarkers in Women with Prior Preeclampsia/HELLP Syndrome
Author(s): Esmee ME Bovee , Martha Gulati , Angela Maas Added: 2 years ago

Demographic

MI/ACS
PCI Outcomes in Women
Author(s): Antonia Sambola , Bruno García Del Blanco , Vijay Kunadian , et al Added: 1 year ago

Vascular Disease and Surgery

MI/ACS
COVID-19: Cardiac Considerations for Athletes
Author(s): Daniel X Augustine , Tracey Keteepe-Arachi , Aneil Malhotra Added: 3 years ago

COVID-19

Demographic
Author(s): Athanasios Koutsoukis , Argyrios Ntalianis , Evangelos Repasos , et al Added: 3 years ago
Cardio-oncology is an emerging field of cardiology that focuses on cardiovascular diseases in patients with cancer. The classic cardio-oncology paradigm is the prevention, diagnosis and treatment of cardiotoxicity resulting from chemotherapy and/or radiotherapy. Diagnosis and treatment of primary and metastatic cardiac tumours as well as cardiac amyloidosis can be considered ‘less classical’… View more

Standards & Guidelines

Prevention & Chronic Conditions
Coronary Microvascular Spasm
Author(s): Shigeo Godo , Jun Takahashi , Takashi Shiroto , et al Added: 1 year ago

Intervention